Astrazeneca PLC (NYSE:AZN) reported 6/30/2017 earnings this Morning, coming in at $0.87 per share, beating Wall Street’s estimates of $0.41 per Share. Revenue for the quarter came in at $5.05 billion beating analyst estimates of $5.04 billion
Analyst Coverage For Astrazeneca PLC (NYSE:AZN)
These are 2 Sell Ratings, 7 Hold Ratings, 10 Buy Ratings .
The current consensus rating for Astrazeneca PLC (NYSE:AZN) is Hold (Score: 2.42) with a consensus target price of $38.46 , a potential (13.31% upside)
Dividend History for Astrazeneca PLC (NYSE:AZN)
- On 2/3/2017 announced a semiannual dividend of $0.95 6.81% with an ex dividend date of 2/15/2017 which will be payable on 2/17/2017.
- On 7/29/2016 announced a dividend of $0.44 with an ex dividend date of 8/10/2016 which will be payable on 8/12/2016.
- On 2/5/2016 announced a dividend of $0.93 with an ex dividend date of 2/17/2016 which will be payable on 2/19/2016.
- On 2/10/2015 announced a semiannual dividend of $1.90 5.57% with an ex dividend date of 2/18/2015 which will be payable on 2/20/2015.
- On 8/1/2014 announced a semiannual dividend of $0.90 2.48% with an ex dividend date of 8/13/2014 which will be payable on 8/15/2014.
- On 2/10/2014 announced a special dividend of $1.90 2.79% with an ex dividend date of 2/19/2014 which will be payable on 2/21/2014.
- On 8/2/2013 announced a semiannual dividend of $0.90 3.52% with an ex dividend date of 8/14/2013 which will be payable on 8/16/2013.
Recent Trading for Astrazeneca PLC (NYSE:AZN) Shares of Astrazeneca PLC closed the previous trading session at 28.69 down -5.25 -15.47% with 4,065,671 shares trading hands.